Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the management of metabolic disorders. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://oisiupip354745.aboutyoublog.com/47851296/semaglutide-a-potential-solution-for-metabolic-disorders